Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024
Shareholders at the upcoming Annual General Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111.1 INR | +8.03% | +8.01% | +22.58% |
05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+22.58% | 341M | |
+17.86% | 25.35B | |
+22.76% | 24.85B | |
-3.93% | 24.58B | |
-17.11% | 24.55B | |
+1.45% | 19.58B | |
+25.04% | 19.24B | |
-0.25% | 19.01B | |
+55.81% | 18.98B | |
-4.65% | 15.43B |